Integra Lifesciences Holdings Corp
NASDAQ:IART
Integra Lifesciences Holdings Corp
NASDAQ:IART
Price:
28.75 USD
-1.47%
Market Closed
Updated:
May 3, 2024
Integra Lifesciences Holdings Corp
Net Income (Common)
|
Integra Lifesciences Holdings Corp
Net Income (Common) Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Integra Lifesciences Holdings Corp
NASDAQ:IART
|
Net Income (Common)
$67.7m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Net Income (Common)
$1.2B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
3%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Net Income (Common)
$1.8B
|
CAGR 3-Years
106%
|
CAGR 5-Years
0%
|
CAGR 10-Years
17%
|
|
|
Stryker Corp
NYSE:SYK
|
Net Income (Common)
$3.4B
|
CAGR 3-Years
34%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
16%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Net Income (Common)
$5.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
17%
|
CAGR 10-Years
9%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Net Income (Common)
$2B
|
CAGR 3-Years
19%
|
CAGR 5-Years
12%
|
CAGR 10-Years
14%
|
See Also
What is Integra Lifesciences Holdings Corp's Net Income (Common)?
Net Income (Common)
67.7m
USD
67.7m
USD
Based on the financial report for Dec 31, 2023, Integra Lifesciences Holdings Corp's Net Income (Common) amounts to 67.7m USD.
What is Integra Lifesciences Holdings Corp's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
2%
2%
Over the last year, the Net Income (Common) growth was -62%. The average annual Net Income (Common) growth rates for Integra Lifesciences Holdings Corp have been -20% over the past three years , 2% over the past five years .
You don't have any saved screeners yet
